VTP-201227

Thuốc Gốc

Small Molecule

VTP-201227 has a novel mechanism of action and is being developed as a topical agent for the treatment of psoriasis with potential extensions into other dermatological indications. It is being developed by Vitae Pharmaceuticals.

Dược Lực Học : VTP-201227 is a potent, selective inhibitor of two specific enzymes that are active in the skin. Therapeutic targeting of these enzymes by VTP-201227 promotes naturally-occurring healing processes within the skin. The compound has been designed to be rapidly inactivated in systemic circulation and thus has the potential to have a more favorable safety profile. In preclinical animal models, VTP-201227 was shown to exhibit a superior therapeutic index compared to other topical dermatology drugs.

Chỉ Định : Investigated for use/treatment in psoriasis and psoriatic disorders.

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05652

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading